J9355 Injection trastuzumab excl biosimi
J-Codes
Also known as: trastuzumab, Herceptin
Injection of trastuzumab excluding biosimilars, an anti-HER2 monoclonal antibody. First-line therapy for HER2-positive breast cancer.
Clinical Context
Standard therapy for HER2-positive breast cancer in early and metastatic settings. Often combined with chemotherapy and other targeted agents.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.